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Abstract: One rare tetracyclic macroline-type indole alkaloid, named rauvoyunine A (1), and two new picraline-type alkaloids  
rauvoyunines B and C (2 and 3) were isolated from the aerial parts of Rauvolfia yunnanensis. Their structures were elucidated on 
the basis of extensive spectroscopic analysis. Compounds 2 and 3 were evaluated for their in vitro cytotoxicity against five human 
tumor cell lines. 
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Introduction 
The plants of genus Rauvolfia, widely distributed in 
America, Africa, Asia, and Oceania,1 are well-known rich 
sources of unique heterocyclic alkaloids with monoterpene 
indole skeletons. These alkaloids have attracted great interests 
from biological and therapeutic aspects, due to their 
anticancer,2 antimalarial,3 antihypertensive,4 and sedative5 
properties. 
Rauvolfia yunnanensis Tsiang, belonging to the Apocynace-
ae, is indigenous to southwestern China, and its roots are  
utilized locally for the remedy of scab1. Recently, several 
structurally interesting indole alkaloids were isolated from this 
plant.6–8 As one part of our research program exploring  
bioactive monoterpene indole alkaloids from Chinese species 
of Rauvolfia, phytochemical analysis from the methanol  
extract of aerial parts of R. yunnanensis led to the isolation of 
three new alkaloids, rauvoyunines A–C (1–3). This paper  
reports the isolation and structure elucidation of new  
compounds and cytotoxic evaluation of selected compounds. 
 
Results and Discussion 
Compound 1, obtained as amorphous powder, has a  
molecular formula of C21H28N2O3 based on HRESIMS (pos.), 
showing a quasi-molecular ion peak at m/z 357.2185 (calc. for 
C21H29N2O3, 357.2178). The UV spectrum showed absorptions 
at λmax 228, 282, and 303 nm typical of a substituted indole 
chromophore.9 The IR spectrum showed absorptions at 3432 
and 1628 cm–1, attributed to hydroxy and olefin groups,  
respectively. The 1H NMR spectrum (Table 1) showed signals 
for an aromatic AMX spin system at δH 6.73 (dd, J = 8.7 and 
2.3 Hz), 6.85 (d, J = 2.3 Hz), and 7.17 (d, J = 8.7 Hz), typical 
of an indole moiety substituted by a hydroxy group at 10 or 11 
position, signals characteristic of an ethylidene group at δH 
1.44 (d, J = 6.8 Hz) and 5.58 (q, J = 6.8 Hz), singlets for N-
methyl groups at δH 2.55 and 3.59, and resonances of two  
hydroxymethyl groups, one at δH 3.75 (dd, J = 10.5 and 3.7 Hz) 
and 3.91 (dd, J = 10.5 and 5.5 Hz), and another at δH 4.02 (2H, 
s). The 13C NMR (DEPT) spectrum (Table 1) exhibited six sp2 
quaternary carbons (δC 151.8, 140.3, 134.0, 132.3, 127.8, and 
106.2), four sp2 methines (δC 124.8, 112.2, 110.6, and 103.4), 
four sp3 methines (δC 58.7, 55.5, 47.7, and 30.2), four sp3 
methylenes (δC 66.0, 64.1, 30.5, and 23.7), and three methyl 
groups (δC 41.5, 29.3, and 13.1). The above-mentioned data, 
together with the presence of nine degrees of unsaturation 
suggested that 1 was an indole alkaloid with tetracyclic  
macroline skeleton.10,11 This conclusion is supported by the 
HMBC (Figure 1) three-bond correlations of H-5 to C-3, C-15, 
and C-17, H-16 to C-6 and C-14, and H-15 to C-3, C-17, and 
C-19. In addition, the m-coupling doublet at δH 6.85 (J = 2.3 
Hz) showed an HMBC correlation with C-7 and a ROESY 
correlation with H-6β, indicating the hydroxyl at C-10. HMBC 
cross-peaks of H-18 to C-19 and C-20, and H-19 to C-15 and 
C-20 located the ethylidene side chain at C-20, and cross-peaks
of H-17 to C-5, C-15, and C-16, and H-21 to C-15, C-19, and 
C-20 revealed that the two hydroxymethyl group was adjacent 
to C-16 and C-20, respectively. The position of each methyl 
group was confirmed by HMBC correlations from N(1)-Me to 
C-2 and C-13, and N(4)-Me to C-3 and C-5. 
The relative stereochemistry of 1 was elucidated by ROESY 
experiments (Figure 1). The ROESY spectrum exhibited  
correlations of H-16↔H-6β and H-3↔N(4)-Me↔H-5, fixing 
the two bridgehead hydrogen atoms as α orientation, revealing 
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the stereochemistry of H-16 as β-oriented. The ROESY  
correlation between H-14α and the hydroxymethyl proton at 
C-20 indicated that C-20 was α-oriented and H-15 was β-
oriented. The ROESY correlations of Me-18↔H-15 and H-
19↔H-21 confirmed that the ethylidene side chain had an E-
configuration. Consequently, the structure of compound 1 was 
determined as shown, named rauvoyunine A. 
Compound 2 was obtained as amorphous powder. Its  
molecular formula was determined to be C23H26N2O6 on the 
basis of HRESIMS (pos.), showing a quasi-molecular ion peak 
at m/z 427.1868 (calc. for C23H27N2O6, 427.1869). The UV 
spectrum showed maximum absorption at 292 nm, and the IR 
spectrum implied the presence of carbonyl (1738 cm–1) 
functionality. The 1H NMR spectra (Table 1) showed the 
presence of three aromatic protons, an ethylidene side chain, a 
methyl ether, and an acetyl. The 13C NMR spectra (Table 1) 
revealed 23 carbon signals due to six sp2 quaternary carbons, 
four sp2 methines, three sp3 quaternary carbons, three sp3 
methines, four sp3 methylenes, and three methyl groups. These 
spectroscopic features suggested that 2 had a picraline-type 
skeleton.13,14 The three observed aromatic resonances at δH 
7.11 (d, J = 8.8 Hz), 6.20 (dd, J = 8.8, 2.2 Hz), and 6.19 (d, J 
= 2.2 Hz) combined with the fact that a hydroxylated carbon 
signal was detected at δC 158.6 (s) suggested that an OH group 
located at C-10 or C-11. Finding HMBC correlation from the 
o-coupling doublet at δH 7.11 (J = 8.8 Hz) to C-7 at δC 53.2 (s) 
and ROESY correlation between the doublet and H-6α further 
confirmed placement of hydroxyl at C-11. Two geminally 
coupled proton signals at δH 3.85 and 4.52 (each d, J = 11.1 Hz) 
showed correlations with an O-acetyl carbonyl carbon at δC 
171.9, indicating that an acetoxy group was located at C-17. 
An methoxy singlet at δH 3.66 showed correlation to C-22 at 
δC 173.7, allowing assignment of methyl ether at C-22 position. 
The ROESY cross-peak between H-17a and H-14β indicated 
that C-17 was β-oriented, which was further supported by the 
presence of an NMR signal of the acetyl methyl group at δH 
1.62 (the noticeable upfield shift being due to the shielding by 
the aromatic ring current).15 ROESY cross-peaks of H-
14α↔H-21α↔H-3 and H-21β↔H-5 revealed that the configu-
ration of H-3 and H-5 were α and β, respectively. The ethyli-
dene moity was assigned to be E-type since the correlations of 
H-18↔H-15 and H-19↔H-21 were observed. Therefore, the 
structure of 2 was unambiguously elucidated as 11-hydroxy-
picraline, named rauvoyunine B. 
Compound 3, obtained as amorphous powder, possessed a 
molecular formula of C32H36N2O9, as evidenced by HRESIMS 
(pos.) at m/z 593.2496 (calc. for C32H37N2O9, 593.2499), in 
combination with 1H and 13C NMR (DEPT) spectra (Table 1), 
and appropriate for 16 degrees of unsaturation. The UV spec-
trum showed maximum absorption at 269 nm. Its IR spectrum 
revealed absorption bands of carbonyl (1722 cm–1). The 1H 
NMR data showed signals of three aromatic protons at δH 6.04 
(br. d, J = 8.3 Hz), 6.26 (br. s), and 7.29 (d, J = 8.3 Hz), an 
ethylidene group at δH 1.62 (d, J = 6.7 Hz) and 5.48 (q, J = 6.7 
Hz), two methoxy groups at δH 3.45 (s) and 3.64 (s), and a 
3′,4′,5′-trimethoxybenzoyloxy unit, based on the presence of 
two aromatic protons at δH 6.94 (2H, s) and three overlapped 
methoxy groups at δH 3.87 (9H, s). The 13C NMR (DEPT) data 
exhibited ten sp2 quaternary carbons, six sp2 methines, three 
sp3 quaternary carbons, three sp3 methines, four sp3 methylenes,
and six methyl groups. These spectroscopic features were 
closely related to those of 2, but it was evident that 3 had a 
trimethoxybenzoyloxy unit instead of the acetoxy moity at C-
17 and a methoxyl group instead of the hydroxy group at C-11. 
This was also supported by HMBC correlations from H-17 to 
C-7′ and correlation from methoxy protons at δH 3.45 (s) to C-
11 at δC 160.1. The ROESY cross-peaks of Me-18↔H-15 and 
H-19↔H-21 confirmed that the ethylidene possessed an E-
configuration. The cross-peak of 17a↔H-14β indicated that 
the stereochemistry of C-16 was identical to that of 2. Since 
the J3 14, J14 15, and J5 6 values were essentially unchanged 
compared to 2, it is safe to deduce that the ring junction stere-
ochemistry remain intact. Thus, the structure of 3 was estab-
lished to be 11-methoxyburnamine-17-O-3′,4′,5′-trimethoxy-
benzoate and named as rauvoyunine C. 
Compounds 2 and 3 were evaluated for their cytotoxicities 
against five human cancer cell lines (HL-60, SMMC-7721,  
A-549, MCF-7, and SW-480) using the MTT method as  
  
Figure 1.  Key HMBC and ROESY correlations of 1. 
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reported previously,15 however, all tested compounds were 
inactive, and they showed IC50 values > 40 μM. 
 
Experimental Section 
General Experimental Procedures. Optical rotations were 
measured on a Jasco P-1020 automatic digital polarimeter. IR 
spectra were obtained using a Bruker Tensor 27 FT-IR  
spectrometer with KBr pellets. NMR spectra were acquired 
with a Bruker DRX-500 instrument at room temperature. 
ESIMS (including HRESIMS) were measured on API QSTAR 
Pulsar i mass spectrometers. Silica gel (200−300 mesh, Qing-
dao Marine Chemical Inc., China) and Sephadex LH-20 
(Amersham Biosciences, Sweden) were used for column 
chromatography. Fractions were monitored by TLC (Qingdao 
Marine Chemical Inc., China) in combination with reversed-
phase HPLC (Agilent 1200, Extend-C18 column, 5 μm, 4.6 × 
150 mm). 
 
Plant Material. The aerial parts of R. yunnanensis were 
collected in Xishuangbanna of Yunnan Province, China, in 
May 2008 and were identified by Prof. Yu Chen of Kunming 
Institute of Botany, Chinese Academy of Sciences. The 
voucher specimen was deposited at BioBioPha Co., Ltd. 
 
Extraction and Isolation. The air-dried and powdered  
aerial parts of R. yunnanensis (6.5 kg) were extracted three 
times with methanol (3 × 50 L, each 3 days) at room tempera-
ture and filtered. The filtrate was evaporated under reduced 
pressure to get a residue (~480 g), which was fractionized by 
silica gel (200–300 mesh) CC, eluted with a gradient solvent 
system of petroleum ether-acetone and then MeOH to yield 
five fractions A–E. Fraction D, eluted by 100% acetone, was 
separated on silica gel (CHCl3-MeOH, 100:1→30:1) to give 
two subfractions D1 and D2, Fr. D2 was further isolated and 
purified by Sephadex LH-20, silica gel (CHCl3-MeOH-
ammonia, 100:1:0.1) to afford 3 (28 mg). Fraction E, eluted by 
100% methanol, was separated on silica gel (CHCl3-MeOH, 
30:1→10:1) to give four subfractions E1–E4, Fr. E4 was  
further isolated and purified by Sephadex LH-20, and then 
silica gel (CHCl3-MeOH-ammonia, 30:1:0.1) to afford 1 (40 
mg) and 2 (11 mg). The retention times (tR) of 1–3 from  
analysis-type HPLC (50%→100% MeOH in H2O over 6.0 min 
followed by 100% MeOH to 10 min, 1.0 ml/min, 20°C) were 
5.8, 4.7, and 6.6 min, respectively. 
 
Rauvoyunine A (1): yellowish, amorphous powder; [α]25 D  + 
5.5 (c 0.10, MeOH); UV (MeOH) max: 216 (sh), 228, 282, 
303, 316 (sh) nm; IR (KBr) max 3432, 2923, 1628, 1467, 1380, 
1158, 1134 cm–1; 1H and 13C NMR data see Table 1; ESIMS 
(pos.): m/z 357 [M + H]+; HRESIMS (pos.): m/z 357.2185 
(calc. for C21H29N2O3, 357.2178). 
 
Table 1. 1H NMR and 13C NMR spectroscopic data for rauvoyunines A−C (1−3) (δ in ppm, J in Hz). 
 
No. 
1a 2a 3b 
δH δC δH δC δH δC 
2  132.3 (s)  109.0 (s)  107.5 (s) 
3 4.39 (dd, 4.2, 2.4) 55.5 (d) 3.48 (br. d, 3.1) 52.7 (d) 3.98 (br. s) 51.9 (d) 
5 3.72 (d, 7.2) 58.7 (d) 4.72 (d, 2.8) 88.1 (d) 5.15 (br. s) 87.4 (d) 
6α  
6β 
3.35 (dd, 16.6, 7.2) 
2.63 (d, 16.6) 23.7 (t) 
2.29 (dd, 14.2, 2.8) 
3.17 (d, 14.2) 45.0 (t) 
2.52 (br. d, 14.7) 
3.17 (d, 14.7) 42.3 (t) 
7  106.2 (s)  53.2 (s)  51.9 (s) 
8  127.8 (s)  126.1 (s)  124.6 (s) 
9 6.85 (d, 2.3) 103.4 (d) 7.11 (d, 8.8) 128.6 (d) 7.29 (d, 8.3) 127.4 (d) 
10  151.8 (s) 6.20 (dd, 8.8, 2.2) 108.0 (d) 6.04 (br. d, 8.3) 106.3 (d) 
11 6.73 (dd, 8.7, 2.3) 112.2 (d)  158.6 (s)  160.1 (s) 
12 7.17 (d, 8.7) 110.6 (d) 6.19 (d, 2.2) 99.5 (d) 6.26 (br. s) 98.2 (d) 
13  134.0 (s)  151.7 (s)  149.1 (s) 
14α 
14β 
2.58 (ddd, 13.7, 13.3, 4.2) 
1.73 (ddd, 13.7, 4.0, 2.4) 30.5 (t) 
2.00 (ddd, 15.1, 4.0, 3.1) 
1.95 (br. d, 15.1) 22.5 (t) 2.11 (2H, s) 21.0 (t) 
15 2.98 (ddd, 13.3, 5.6, 4.0) 30.2 (d) 3.36 (br. s) 36.3 (d) 3.46 (br. s) 34.5 (d) 
16 1.86 (ddd, 5.6, 5.5, 3.7) 47.7 (d)  57.4 (s)  56.6 (s) 
17a 
17b 
3.91 (dd, 10.5, 5.5) 
3.75 (dd, 10.5, 3.7) 64.1 (t) 
4.52 (d, 11.1) 
3.85 (d, 11.1) 68.2 (t) 
4.61 (d, 11.2) 
4.17 (d, 11.2) 66.7 (t) 
18 1.44 (d, 6.8) 13.1 (q) 1.59 (d, 6.5) 13.7 (q) 1.62 (d, 6.7) 13.4 (q) 
19 5.58 (q, 6.8) 124.8 (d) 5.43 (q, 6.5) 122.4 (d) 5.48 (q, 6.7) 123.6 (d) 
20  140.3 (s) 137.7 (s) 132.0 (s)
21α 
21β 4.02 (2H, s) 66.0 (t) 
3.72 (br. d, 17.7) 
3.20 (d, 17.7) 46.9 (t) 
3.90 (br. d, 17.5) 
3.39 (d, 17.5) 45.9 (t) 
22    173.7 (s)  171.9 (s) 
NMe(1) 3.59 (s) 29.3 (q)     
NMe(4) 2.55 (s) 41.5 (q)     
COOMe   3.66 (s) 52.1 (q) 3.64 (s) 51.7 (q) 
OMe(11)     3.45 (s) 55.0 (q) 
CH3COO   1.62 (s) 20.2 (q)   
CH3COO    171.9 (s)   
OMe(3′, 5′)     3.87 (s) 56.1 (q) 
OMe(4′)   3.87 (s) 60.8 (q)
1′      124.3 (s) 
2′, 6′     6.94 (s) 106.7 (d) 
3′, 5′      152.5 (s) 
4′      142.0 (s) 
7′      164.6 (s) 
aRecorded in CD3OD. bRecorded in CDCl3. 
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Rauvoyunine B (2): yellowish, amorphous powder; [α]25 D  – 
92.0 (c 0.19, MeOH); UV (MeOH) max: 231 (sh), 292 nm; IR 
(KBr) max 3440, 2951, 1738, 1622, 1454, 1385, 1236, 1146, 
1114, 1048 cm–1; 1H and 13C NMR data see Table 1; ESIMS 
(pos.): m/z 427 [M + H]+; HRESIMS (pos.): m/z 427.1868 
(calc. for C23H27N2O6, 427.1869). 
 
Rauvoyunine C (3): yellowish, amorphous powder; [α]25 D  – 
116.8 (c 0.18, MeOH); UV (MeOH) max: 269, 293 (sh) nm; 
IR (KBr) max 3433, 2945, 1722, 1625, 1590, 1503, 1459, 
1384, 1416, 1335, 1226, 1127 cm–1; 1H and 13C NMR data see 
Table 1; ESIMS (pos.): m/z 593 [M + H]+; HRESIMS (pos.): 
m/z 593.2496 (calc. for C32H37N2O9, 593.2499). 
 
Cytotoxicity Assay. The cytotoxicity assay was performed 
according to the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide] method,16 by use of the follow-
ing five human cancer cell lines: human myeloid leukemia 
HL-60, hepatocellular carcinoma SMMC-7721, lung cancer A-
549, breast cancer MCF-7, and colon cancer SW-480. The 
IC50 values were calculated by Reed and Muench’s method.17 
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